Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
-
Published:2023-12
Issue:1
Volume:21
Page:13
-
ISSN:1687-157X
-
Container-title:Journal of Genetic Engineering and Biotechnology
-
language:en
-
Short-container-title:Journal of Genetic Engineering and Biotechnology
Author:
Ragab Halla M.ORCID,
Ezzat Wafaa M.,
Hassan Eman Mahmoud,
El Maksoud Nabila Abd,
Afify Mie,
Abd El-Maksoud Mohamed D.E.,
Elaziz Wafaa Abd
Funder
National Research centre
Subject
Genetics,Biotechnology
Reference50 articles.
1. Nonalcoholic fatty liver disease cirrhosis: a review of its epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis;Li;Can J Gastroenterol Hepatol,2018
2. Nonalcoholic fatty liver disease: a systematic review;Rinella;Jama.,2015
3. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018
4. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology.,2015
5. Hochreuter MY, Dall M, Treebak JT, Barrès R (2022) MicroRNAs in non-alcoholic fatty liver disease: progress and perspectives. Molecular. Metabolism.:101581. https://doi.org/10.1016/j.molmet.2022.101581
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献